Retrospective study of management of uterine sarcomas at Oxford 1990-1998: role of adjuvant treatment.
Clin Oncol (R Coll Radiol)
; 14(1): 54-61, 2002 Feb.
Article
in En
| MEDLINE
| ID: mdl-11899904
ABSTRACT
We report a retrospective study of 47 consecutive patients with uterine sarcoma treated at the Churchill Hospital in Oxford between 1990-1998. The mainstay of treatment was surgery with adjuvant chemotherapy and radiotherapy reserved for selected patients with early stage disease. Overall 1 and 2 year survival was 49% and 30% respectively compared with 73% and 55% in the group who received adjuvant chemotherapy/radiotherapy. Median survival was 11 months for the group as a whole compared to 32.9 months in the adjuvant therapy group. This is a retrospective review with small numbers and considerable selection bias, however, given the poor survival of patients with this disease, adjuvant treatment should be considered in future trials of patients with uterine sarcoma.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoma
/
Uterine Neoplasms
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Clin Oncol (R Coll Radiol)
Journal subject:
NEOPLASIAS
Year:
2002
Document type:
Article
Affiliation country:
United kingdom